Takeda Pharmaceutical Company News

News on Takeda Pharmaceutical Company (Ticker: 4502) continually updated from thousands of sources around the net.

Friday May 25 | Drugs.com

Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil

OSAKA, Japan, and SO JERNIMO, Brazil, May 25, 2012/PRNewswire-FirstCall/ --Takeda Pharmaceutical Company Limited and Multilab Industria e Comercio de Produtos Farmaceuticos Ltda.

Comment?

Wed May 23, 2012

Freshnews

Millennium and Takeda Announce Presentations for Key Investigational...

CAMBRIDGE, Mass. -- -- Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that 101 abstracts featuring the Company's oncology molecules have been accepted at the annual meeting of the American Society of Clinical Oncology being held in Chicago, Illinois, June 1-5, 2012.

Comment?

Fri May 11, 2012

Medical News

Top-line results from Takeda vedolizumab phase 3 trial on Crohn's disease

Takeda Pharmaceutical Company Limited today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial.

Comment?

Thu Apr 26, 2012

PR-inside.com

"Takeda Pharmaceutical Company Limited (4502) - Financial and...

Takeda Pharmaceutical Company Limited - Financial and Strategic SWOT Analysis Review Summary Takeda Pharmaceutical Company Limited is a Japan-based pharmaceutical company.

Comment?

Wed Apr 25, 2012

Freshnews

Takeda Receives Complete Response Letter from the FDA for Type 2...

Takeda Receives Complete Response Letter from the FDA for Type 2 Diabetes Investigational Therapies Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone DEERFIELD, Ill.

Comment?